Literature DB >> 33108113

Journal Club-Severe Acute Respiratory Syndrome Coronavirus-2: Impact on COPD Patients.

Ron Balkissoon1.   

Abstract

Entities:  

Keywords:  COVID-19; SARS-CoV-2; chronic obstructive pulmonary disease; copd; coronavirus disease-2019; severe acute respiratory syndrome coronavirus-2

Year:  2020        PMID： 33108113      PMCID： PMC7883907          DOI： 10.15326/jcopdf.7.4.2020.0188

Source DB:  PubMed          Journal:  Chronic Obstr Pulm Dis        ISSN： 2372-952X


× No keyword cloud information.
  19 in total

1.  Risk of Pneumonia with Different Inhaled Corticosteroids in COPD Patients: A Meta-Analysis.

Authors:  Qian Zhang; Shuo Li; Wei Zhou; Xia Yang; Jinna Li; Jie Cao
Journal:  COPD       Date:  2020-07-09       Impact factor: 2.409

2.  Long-term impact of inhaled corticosteroid use in asthma and chronic obstructive pulmonary disease (COPD): Review of mechanisms that underlie risks.

Authors:  Aran Singanayagam; Sebastian L Johnston
Journal:  J Allergy Clin Immunol       Date:  2020-01-14       Impact factor: 10.793

3.  Corticosteroids, COVID-19 pneumonia, and acute respiratory distress syndrome.

Authors:  Michael A Matthay; Katherine D Wick
Journal:  J Clin Invest       Date:  2020-12-01       Impact factor: 14.808

4.  Clinical Use of Short-Course and Low-Dose Corticosteroids in Patients With Non-severe COVID-19 During Pneumonia Progression.

Authors:  Zhiliang Hu; Yanling Lv; Chuanjun Xu; Wenkui Sun; Wei Chen; Zhihang Peng; Chen Chen; Xiang Cui; Damin Jiao; Cong Cheng; Yun Chi; Hongxia Wei; Chunmei Hu; Yi Zeng; Xia Zhang; Yongxiang Yi
Journal:  Front Public Health       Date:  2020-07-03

5.  COVID-19-related Genes in Sputum Cells in Asthma. Relationship to Demographic Features and Corticosteroids.

Authors:  Michael C Peters; Satria Sajuthi; Peter Deford; Stephanie Christenson; Cydney L Rios; Michael T Montgomery; Prescott G Woodruff; David T Mauger; Serpil C Erzurum; Mats W Johansson; Loren C Denlinger; Nizar N Jarjour; Mario Castro; Annette T Hastie; Wendy Moore; Victor E Ortega; Eugene R Bleecker; Sally E Wenzel; Elliot Israel; Bruce D Levy; Max A Seibold; John V Fahy
Journal:  Am J Respir Crit Care Med       Date:  2020-07-01       Impact factor: 21.405

6.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.

Authors:  Chaolin Huang; Yeming Wang; Xingwang Li; Lili Ren; Jianping Zhao; Yi Hu; Li Zhang; Guohui Fan; Jiuyang Xu; Xiaoying Gu; Zhenshun Cheng; Ting Yu; Jiaan Xia; Yuan Wei; Wenjuan Wu; Xuelei Xie; Wen Yin; Hui Li; Min Liu; Yan Xiao; Hong Gao; Li Guo; Jungang Xie; Guangfa Wang; Rongmeng Jiang; Zhancheng Gao; Qi Jin; Jianwei Wang; Bin Cao
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

7.  Cardiovascular comorbidity and its impact on patients with COVID-19.

Authors:  Wei-Jie Guan; Wen-Hua Liang; Jian-Xing He; Nan-Shan Zhong
Journal:  Eur Respir J       Date:  2020-06-11       Impact factor: 16.671

8.  The proper use of corticosteroids for 2019-nCov pneumonia: Towards promising results?

Authors:  Lucio Boglione; Roberto Rostagno; Federica Poletti; Roberta Moglia; Bianca Bianchi; Maria Esposito; Stefano Biffi; Silvio Borrè
Journal:  J Infect       Date:  2020-08-05       Impact factor: 6.072

9.  Inhibitory effects of glycopyrronium, formoterol, and budesonide on coronavirus HCoV-229E replication and cytokine production by primary cultures of human nasal and tracheal epithelial cells.

Authors:  Mutsuo Yamaya; Hidekazu Nishimura; Xue Deng; Mitsuru Sugawara; Oshi Watanabe; Kazuhiro Nomura; Yoshitaka Shimotai; Haruki Momma; Masakazu Ichinose; Tetsuaki Kawase
Journal:  Respir Investig       Date:  2020-02-21

10.  ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19.

Authors:  Janice M Leung; Chen X Yang; Anthony Tam; Tawimas Shaipanich; Tillie-Louise Hackett; Gurpreet K Singhera; Delbert R Dorscheid; Don D Sin
Journal:  Eur Respir J       Date:  2020-05-14       Impact factor: 16.671
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.